(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.86% $ 134.26
Live Chart Being Loaded With Signals
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services...
Stats | |
---|---|
Dagens volum | 579 272 |
Gjennomsnittsvolum | 1.05M |
Markedsverdi | 14.92B |
EPS | $0 ( 2024-04-25 ) |
Neste inntjeningsdato | ( $2.32 ) 2024-07-24 |
Last Dividend | $0.750 ( 2024-04-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 18.09 |
ATR14 | $0.0790 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-22 | Gregg Vicky B | Buy | 81 | Common Stock |
2024-04-22 | Kuppusamy Karthik | Buy | 45 | Common Stock |
2024-04-22 | Plewman Patrick | Buy | 69 | Common Stock |
2024-04-22 | Samad Sam | Buy | 24 | Common Stock |
2024-04-01 | Ring Timothy M | Buy | 311 | Phantom Stock Units |
INSIDER POWER |
---|
70.91 |
Last 98 transactions |
Buy: 293 398 | Sell: 50 988 |
Volum Korrelasjon
Quest Diagnostics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
LLY | 0.865 |
PCK | 0.863 |
PFE | 0.858 |
JNJ | 0.856 |
MOH | 0.848 |
CHAD | 0.846 |
XLV | 0.841 |
CLII | 0.839 |
ADM | 0.837 |
EVTL | 0.835 |
10 Mest negative korrelasjoner | |
---|---|
YSAC | -0.949 |
MTW | -0.895 |
MNSO | -0.887 |
BH | -0.878 |
STLA | -0.877 |
STN | -0.874 |
RDW | -0.871 |
NOA | -0.867 |
NGL-PC | -0.862 |
NGL-PB | -0.859 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Quest Diagnostics Inc Korrelasjon - Valuta/Råvare
Quest Diagnostics Inc Økonomi
Annual | 2023 |
Omsetning: | $9.25B |
Bruttogevinst: | $2.96B (32.00 %) |
EPS: | $7.59 |
FY | 2023 |
Omsetning: | $9.25B |
Bruttogevinst: | $2.96B (32.00 %) |
EPS: | $7.59 |
FY | 2022 |
Omsetning: | $9.88B |
Bruttogevinst: | $3.43B (34.74 %) |
EPS: | $8.12 |
FY | 2021 |
Omsetning: | $10.79B |
Bruttogevinst: | $4.21B (39.02 %) |
EPS: | $16.91 |
Financial Reports:
No articles found.
Quest Diagnostics Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.660 (N/A) |
$0.660 (N/A) |
$0.660 (N/A) |
$0.710 (N/A) |
$0.710 (N/A) |
$0.710 (N/A) |
$0.710 (N/A) |
$0.750 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0750 | 2004-01-06 |
Last Dividend | $0.750 | 2024-04-05 |
Next Dividend | $0 | N/A |
Payout Date | 2024-04-22 | |
Next Payout Date | N/A | |
# dividends | 82 | -- |
Total Paid Out | $26.61 | -- |
Avg. Dividend % Per Year | 1.55% | -- |
Score | 5.89 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.66 | |
Div. Directional Score | 9.84 | -- |
Year | Amount | Yield |
---|---|---|
2004 | $0.300 | 0.83% |
2005 | $0.345 | 0.73% |
2006 | $0.390 | 0.76% |
2007 | $0.400 | 0.78% |
2008 | $0.400 | 0.77% |
2009 | $0.400 | 0.76% |
2010 | $0.400 | 0.65% |
2011 | $0.400 | 0.73% |
2012 | $0.680 | 1.18% |
2013 | $1.200 | 2.05% |
2014 | $1.290 | 2.44% |
2015 | $1.470 | 2.13% |
2016 | $1.580 | 2.23% |
2017 | $1.800 | 1.95% |
2018 | $1.950 | 1.97% |
2019 | $2.12 | 2.58% |
2020 | $2.21 | 2.09% |
2021 | $2.42 | 2.00% |
2022 | $2.60 | 1.58% |
2023 | $2.79 | 1.79% |
2024 | $1.460 | 1.04% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0911 | 1.500 | 8.18 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0606 | 1.200 | 7.98 | 9.57 | [0 - 0.3] |
returnOnEquityTTM | 0.133 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.377 | -1.000 | 6.23 | -6.23 | [0 - 1] |
currentRatioTTM | 0.970 | 0.800 | -0.152 | -0.122 | [1 - 3] |
quickRatioTTM | 0.782 | 0.800 | -0.109 | -0.0868 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.349 | -1.500 | 4.19 | -6.29 | [0 - 0.6] |
interestCoverageTTM | 7.95 | 1.000 | 8.17 | 8.17 | [3 - 30] |
operatingCashFlowPerShareTTM | 12.00 | 2.00 | 6.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.53 | 2.00 | 5.73 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.756 | -1.500 | 6.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.327 | 1.000 | 7.88 | 7.88 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.142 | 1.000 | 9.16 | 9.16 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.274 | 1.000 | 9.59 | 9.59 | [0.2 - 2] |
assetTurnoverTTM | 0.666 | 0.800 | 8.90 | 7.12 | [0.5 - 2] |
Total Score | 12.03 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 17.62 | 1.000 | 8.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.133 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.53 | 2.00 | 7.16 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.15 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 12.00 | 2.00 | 6.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.377 | 1.500 | 6.23 | -6.23 | [0 - 1] |
pegRatioTTM | 0.619 | 1.500 | 9.21 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.143 | 1.000 | 8.91 | 0 | [0.1 - 0.5] |
Total Score | 7.66 |
Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.